Shanghai Lunsheng Information Technology Co., Ltd. announced that it will receive CNY 8,100,000 in an equity round of funding on January 21, 2020. The transaction will include participation from new investor Shanghai Haohai Biological Technology Co., Ltd. (SEHK:6826) for CNY 7,600,000, for a 19% stake in the company and returning investor Shanghai Haoyang Enterprise Management Co., Ltd. for CNY 2,400,000. Post the transaction the registered capital of the company will increase by CNY 2,166,700 to CNY 8,666,700. Post the transaction the shareholding of existing investors Wu Xuejiao will reduce from 57.69% to 43.27%, Shanghai Haoyang Enterprise Management Co., Ltd. will reduce from 30.77% to 29.08% and Shanghai Nadan Enterprise Management Center (General Partnership) will reduce from 11.54% to 8.65%.